Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study.

Umehara K, Saito Y, Hirate D, Kooka A, Fujibayashi R, Takasaki S, Shimoguchiya T, Kusakabe A, Hatakeyama T, Hasegawa Y, Shimizu A, Ota A, Maeda K, Watanabe T, Takada S, Obara T, Nagashima H, Sagawa T, Fujikawa K, Kawaguchi H

Open source

DOI: 10.21873/anticanres.18207
Published: 2026 Jun
Container: Anticancer research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21873/anticanres.18207,
  title = {Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study.},
  author = {Umehara K and Saito Y and Hirate D and Kooka A and Fujibayashi R and Takasaki S and Shimoguchiya T and Kusakabe A and Hatakeyama T and Hasegawa Y and Shimizu A and Ota A and Maeda K and Watanabe T and Takada S and Obara T and Nagashima H and Sagawa T and Fujikawa K and Kawaguchi H},
  year = {2026},
  journal = {Anticancer research},
  doi = {10.21873/anticanres.18207},
  url = {https://doi.org/10.21873/anticanres.18207}
}

RIS

TY  - JOUR
TI  - Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study.
AU  - Umehara K
AU  - Saito Y
AU  - Hirate D
AU  - Kooka A
AU  - Fujibayashi R
AU  - Takasaki S
AU  - Shimoguchiya T
AU  - Kusakabe A
AU  - Hatakeyama T
AU  - Hasegawa Y
AU  - Shimizu A
AU  - Ota A
AU  - Maeda K
AU  - Watanabe T
AU  - Takada S
AU  - Obara T
AU  - Nagashima H
AU  - Sagawa T
AU  - Fujikawa K
AU  - Kawaguchi H
PY  - 2026
JO  - Anticancer research
DO  - 10.21873/anticanres.18207
UR  - https://doi.org/10.21873/anticanres.18207
ER  -

APA

K, U., Y, S., D, H., A, K., R, F., S, T., T, S., A, K., T, H., Y, H., A, S., A, O., K, M., T, W., S, T., T, O., H, N., T, S., K, F., & H, K. (2026). Antiemetic Efficacy of Aprepitant in Cisplatin-Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study.. Anticancer research. https://doi.org/10.21873/anticanres.18207

Source records

pubmed · retrieved 2026-09-25T05:44:46.941Z